A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes
Crossref DOI link: https://doi.org/10.1007/s00262-016-1913-7
Published Online: 2016-10-19
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chae, Young Kwang
Chiec, Lauren
Mohindra, Nisha
Gentzler, Ryan
Patel, Jyoti
Giles, Francis
License valid from 2016-10-19